Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride Bupivacaine

NANot yet recruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 15, 2025

Study Completion Date

December 20, 2025

Conditions
Postoperative Pain, AcuteLung Cancer
Interventions
PROCEDURE

Liposomal Bupivacaine intercostal nerve block

Ultrasound-guided intercostal nerve block with liposomal bupivacaine 266 mg (20 mL total; 4 mL per intercostal space at the incision and adjacent spaces), performed at the end of surgery before emergence from anesthesia. All patients receive standard postoperative analgesia with intravenous patient-controlled opioid analgesia.

PROCEDURE

Bupivacaine Hydrochloride intercostal nerve block

Ultrasound-guided intercostal nerve block with 0.25% bupivacaine hydrochloride (20 mL total; 4 mL per intercostal space at the incision and adjacent spaces), performed at the end of surgery before emergence from anesthesia. All patients receive standard postoperative analgesia with intravenous patient-controlled opioid analgesia.

OTHER

Standard Postoperative Analgesia

No intercostal nerve block. Patients receive standard postoperative analgesia consisting of an intravenous patient-controlled opioid pump per institutional protocol.

All Listed Sponsors
lead

Shanghai Pulmonary Hospital, Shanghai, China

OTHER